JNJ News and Press, Johnson & Johnson From 03/06/26

2026-03-06 18:03:48 ET Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, w...

2026-03-06 15:00:57 ET More on the markets How The Mideast War Impacts Oil, Gas, And U.S. Stocks February Jobs Report: Worst Private Sector Performance Since 2020 Early Impact Of Iran War Is Low, But Economic Risks Are Rising Single-stock volatility soars pas...

2026-03-06 12:34:31 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Presents at TD Cowen 46th Annual Health Care Conference Transcript Johnson & Johnson: Strong Run May Be Ending (Rating Downgrade) Q4 Healthcare Dividends: Johnson & Johnson Kept ...

2026-03-06 10:45:02 ET More on Pfizer, Merck, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks AbbVie: Stabilizes Near $233 While Testing Resistance Pfizer's Portfolio Renewal In Progress - High Yields For The Patient China approves Pfizer’s GLP-1 d...

2026-03-05 16:02:27 ET More on dividend ETFs SCHD: When AI Hype Fades And Geopolitics Bite Vanguard Dividend Appreciation Index Fund ETF: Quality Discipline For Turbulent Times SCHD: Aren't You Glad You Didn't Sell? Yield strategies shine: Dividend funds deli...

Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASP...

2026-03-05 14:49:08 ET More on Dow Jones Industrial Average Index Why February's CPI Report Matters More Than Ever Amid War-Driven Inflation SPY Is Now A Tech ETF: Building A Quantitatively Optimized 'Strong Buy' Alternative The Web Of AI Circular Deals Begins To Unr...

2026-03-05 14:37:33 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Presents at TD Cowen 46th Annual Health Care Conference Transcript Johnson & Johnson: Strong Run May Be Ending (Rating Downgrade) Q4 Healthcare Dividends: Johnson & Johnson Kept ...

2026-03-05 09:30:16 ET GAD Therapies Market Set to Explode to $4.26B by 2033 as Demand Rockets for Innovative Anxiety Solutions New York, NY –March 5, 2026 – Market News Updates News Commentary – Treatments for Generalized Anxiety Disorder (GAD) ...

2026-03-04 19:42:29 ET It has been an interesting start to 2026. There has been back-and-forth on tariffs that have introduced volatility. We have seen an AI-disruption fear sweep the market and knock several sectors back that could, in theory, be displaced by AI, adding volatility. We ...